administration of UI068
KUP-UI068-101
Phase 1 small_molecule completed
Quick answer
administration of UI068 for Diabetes Mellitus, Type 2 is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed